P
Patricia L. Adams
Researcher at Wake Forest University
Publications - 54
Citations - 3684
Patricia L. Adams is an academic researcher from Wake Forest University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 27, co-authored 54 publications receiving 3379 citations. Previous affiliations of Patricia L. Adams include Harvard University & Wake Forest Baptist Medical Center.
Papers
More filters
Journal ArticleDOI
Consensus statement on the live organ donor.
M. Abecassis,Mark Raymond Adams,Patricia L. Adams,Robert M. Arnold,C R Atkins,Mark L. Barr,William M. Bennett,Margaret J. Bia,David M. Briscoe,James Burdick,Robert J. Corry,John M. Davis,Francis L. Delmonico,Robert S. Gaston,William E. Harmon,Cheryl L. Jacobs,Jeffrey P. Kahn,A. B. Leichtman,Charles Miller,D Moss,J M Newmann,L S Rosen,Laura A. Siminoff,Aaron Spital,Vaughn A. Starnes,C Thomas,L S Tyler,L Williams,F H Wright,Stuart J. Youngner +29 more
TL;DR: The person who gives consent to be a live organ donor should be competent, willing to donate, free from coercion, medically and psychosocially suitable, fully informed of the risks and benefits as a donor, and fully informed about the risks, benefits, and alternative treatment available to the recipient.
Journal ArticleDOI
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
Krista L. Lentine,Bertram L. Kasiske,Andrew S. Levey,Patricia L. Adams,Josefina Alberú,Mohamed A. Bakr,Lorenzo Gallon,Catherine A. Garvey,S. Guleria,Philip Kam-Tao Li,Dorry L. Segev,Sandra J. Taler,Kazunari Tanabe,Linda Wright,Martin Zeier,Michael Cheung,Amit X. Garg +16 more
TL;DR: The guideline work group concluded that a comprehensive approach to risk assessment should replace decisions based on assessments of single risk factors in isolation, and proposed a framework for quantitative risk assessment in the donor candidate evaluation and defensible shared decision making.
Journal ArticleDOI
The APOL1 gene and allograft survival after kidney transplantation.
Amber Reeves-Daniel,John A. DePalma,Anthony J. Bleyer,Michael V. Rocco,Mariana Murea,Patricia L. Adams,Carl D. Langefeld,Donald W. Bowden,Pamela J. Hicks,Robert J. Stratta,Jen Jar Lin,David F. Kiger,Michael D. Gautreaux,Jasmin Divers,Barry I. Freedman +14 more
TL;DR: Kidneys from AA deceased donors harboring two APOL1 risk variants failed more rapidly after renal transplantation than those with zero or one risk variants, and genotyping could improve the donor selection process and maximize long‐term renal allograft survival.
Journal ArticleDOI
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
Krista L. Lentine,Bertram L. Kasiske,Andrew S. Levey,Patricia L. Adams,Josefina Alberú,Mohamed A. Bakr,Lorenzo Gallon,Catherine A. Garvey,S. Guleria,Philip Kam-Tao Li,Dorry L. Segev,Sandra J. Taler,Kazunari Tanabe,Linda Wright,Martin Zeier,Michael Cheung,Amit X. Garg +16 more
TL;DR: The approach to simultaneous consideration of each candidate’s profile of demographic and health characteristics advances a new framework for assessing donor candidate risk and for defensible shared decision making.
Journal ArticleDOI
The report of a national conference on the wait list for kidney transplantation.
Robert S. Gaston,Gabriel M. Danovitch,Patricia L. Adams,James J. Wynn,Robert M. Merion,Mark H. Deierhoi,Robert A. Metzger,J. Michael Cecka,William E. Harmon,A. B. Leichtman,Aaron Spital,Emily A. Blumberg,Charles A. Herzog,Robert A. Wolfe,Dolly B. Tyan,John P. Roberts,Richard J. Rohrer,Friedrich K. Port,Francis L. Delmonico +18 more
TL;DR: The issues and recommendations regarding the waiting list for kidney transplantation addressed in the Philadelphia meeting are summarized.